FDA Radiology AI Devices

The SPECTRALIS with Flex Module is an advanced eye imaging device designed for non-contact visualization of the posterior segment and vasculature of the retina and choroid in adults and pediatric patients, including those in supine (lying down) position. It helps ophthalmologists detect and monitor various eye conditions by providing high-quality images of eye structures, enabling improved diagnosis and management.

The AEYE-DS device helps healthcare providers automatically detect more than mild diabetic retinopathy in adults with diabetes by analyzing retinal images taken by specific fundus cameras. It uses AI technology to analyze the images and provides diagnostic screening results, improving early detection and management of diabetic eye disease.

EyeArt v2.2.0 is an AI-based software device designed to automatically detect more than mild and vision-threatening diabetic retinopathy in retinal fundus images. It assists healthcare providers by analyzing images captured from specific retinal cameras and providing diagnostic screening results to help identify retinal disease in adults with diabetes, facilitating early detection and treatment.

AEYE-DS is an AI-powered retinal diagnostic software that helps healthcare providers automatically detect more than mild diabetic retinopathy in adults with diabetes using fundus images from a Topcon NW400 camera. It improves screening efficiency by analyzing images to identify disease presence, helping to guide timely patient care.

IDx-DR v2.3 is an AI-based diagnostic software that automatically detects more than mild diabetic retinopathy from retinal images captured with a Topcon NW400 fundus camera. It helps healthcare providers identify patients who need referral to eye care professionals, improving timely diagnosis and management of diabetic retinopathy.

IDx-DR is an AI software device designed to help healthcare providers automatically detect more than mild diabetic retinopathy in diabetic adult patients using retinal fundus images. It assists clinicians by analyzing images captured from a specialized retinal camera and providing a diagnostic screening result, thus potentially improving early detection and management of diabetic eye disease.

EyeArt is an AI-powered medical software that analyzes retinal images to automatically detect more than mild diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes. It is designed to assist healthcare providers in primary care and eye care settings by providing rapid and reliable detection using color fundus images captured by specified retinal cameras.

The CLARUS 700 by Carl Zeiss Meditec, Inc. is a high-resolution ophthalmic imaging device used for capturing and analyzing images of the retina and ocular structures. It supports multiple imaging modes including true color, autofluorescence, and fluorescein angiography, aiding clinicians in diagnosing and monitoring retinal diseases by providing widefield and ultra-widefield views with AI assistance for optic nerve detection and montage creation. The device improves patient comfort and provides advanced tools for image annotation and review.

The IRIS Intelligent Retinal Imaging System is a web-based software that stores, manages, and displays retinal images and diagnostic data from computerized instruments. It allows licensed clinicians to review fundus images and visual field data to evaluate and diagnose retinal conditions such as diabetic retinopathy, glaucoma, and macular degeneration, thereby assisting in patient care and follow-up.